The costs of imaging services have risen at twice the rate of other health technology sectors such as pharmaceuticals, and they are rapidly approaching 10 percent of total healthcare costs. While imaging has changed medicine for the better, some of the growth can be attributed to inappropriate imaging—costing between $3 billion and $10 billion annually.

There’s a wealth of usable data in every imaging practice, including performance benchmarks, scanner data and EHR records. Building a business analytics framework to extract and visualize data can be challenging, but the use cases demonstrate impressive gains in productivity and value.

Metastatic lung cancer has several options for treatment, but ablation should the first choice therapy, according to an RSNA 2016 presentation delivered by Chief of Interventional Radiology Stephen B. Solomon, MD, of Memorial-Sloan Kettering Cancer Center.

With the Medicare Access and CHIP Reauthorization Act (MACRA) and Merit-Based Incentive Payment System (MIPS) going live in 2017, a substantial amount of reimbursement dollars will be tied to quality metrics. Radiology practices must leverage performance data and EHR records to receive the biggest possible reimbursement.

Many American physicians aren’t accustomed to treating neglected tropical diseases (NTD), simply because many of their patients just don’t catch them. Illnesses like leprosy, Chagas disease and leishmaniasis, rarely plague people in the U.S.